This compound is a pharmaceutical intermediate featuring a benzoic acid moiety linked to an isoxazole ring and a pentoxyphenyl substituent. It is primarily utilized in research and manufacturing settings as a building block for active pharmaceutical ingredients.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 179162-55-1
4-Bromo-2-fluoro-benzoic acid methyl ester
Pharmaceutical intermediate
3-aminoazepan-2-one
pharmaceutical intermediate
Amikacin Impurity 11
Amikacin impurity reference standard
(S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-2-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydroxycyclohexyl)-2-hydroxybutanamide
Amikacin impurity reference standard
4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoic acid
PDTXSIGPZDVVIX-UHFFFAOYSA-N
CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)O